Kevin Forrest, Kate Therapeutics CEO

Af­ter gene ther­a­py deaths, Astel­las to re­vis­it fa­tal neu­ro­mus­cu­lar con­di­tion in part­ner­ship with biotech start­up

Four years ago, a biotech com­pa­ny pre­sent­ed da­ta so pow­er­ful it made sci­en­tists cry.
Speak­ing to a packed room at an

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.